Skip to Content

  • Search

View Additional Section Content

A parallel Group, Double-Blind, Randomized, Placebo Controlled, Dose-Ranging Phase 2 Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of ALD403 Administered Intravenously in Patients with Chronic Migraine

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT02275117?term=ALD403&rank=2

Clinical Trial Categories

  • Migraine
Contact
Jennifer McGowan at 215-327-0161

Location

  • Abington Neurological Associates, Ltd

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM

Clinical Trials Details